Volume 18, Issue 10 (1-2020)
JRUMS 2020, 18(10): 1017-1034 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Norouzi H, Rabbani Khorasgani M, Danesh A. An Increase in Antimicrobial Effects of Standard Antibiotics in Combination with the Active Metabolites Isolated from Marine Streptomyces: A Laboratory Study. JRUMS 2020; 18 (10) :1017-1034
URL: http://journal.rums.ac.ir/article-1-4512-en.html
URL: http://journal.rums.ac.ir/article-1-4512-en.html
Mashhad University of Medical Sciences
Full-Text [PDF 510 kb]
(750 Downloads)
| Abstract (HTML) (2190 Views)
Full-Text: (3053 Views)
An Increase in Antimicrobial Effects of Standard Antibiotics in Combination with the Active Metabolites Isolated from Marine Streptomyces: A Laboratory Study
H. Norouzi[1], M. Rabbani Khorasgani[2], A. Danesh[3]
Received: 10/11/2018 Sent for Revision: 04/02/2019 Received Revised Manuscript: 16/06/2019 Accepted: 01/07/2019
Background and Objectives: Combination therapy has been considered as a potential approach to overcome antimicrobial resistance. In this study the antimicrobial effects of active compounds produced by some marine Streptomyces spp. in combination with some standard antibiotics against multidrug-resistant pathogens was investigated.
Materials and Methods: In this laboratory study, the bacteria isolated from Caspian Sea were tested for their ability to produce antimicrobial compounds active against some drug-resistant pathogens using disc diffusion methods. Then, the producer strains were cultivated in suitable liquid media. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the ethyl acetate extracts were measured against some drug-resistant species including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) using microbroth dilution technique. Data was analysed using paired t-test.
Results: In the first screening, strains MN2, MN39, MN40 and MN41 showed a broad antimicrobial activity against MRSA, VRE, Salmonella typhi and pseudomonas aeruginosa, among which, the best MIC against MRSA was obtained from strain MN39 at 280 (µg/ml). These extracts in combination with some standard antibiotics resulted in a noticeable improved antimicrobial activity against multidrug-resistant pathogens, while in some cases the activity was decreased.
Conclusion: The bioactive compounds produced by actinomyces possess remarkable antimicrobial properties against drug-resistant pathogens when used in a combination therapy with standard antibiotics which requires further research in the future.
Key words: Marine Streptomyces, Multidrug-resistant pathogens, Antimicrobial effects
Funding: This study did not have any funds.
Conflict of interest: None declared.
Ethical approval: The Ethics Committee of Mashhad University of Medical Sciences approved the study (IR.MUMS.REC.1394.556).
How to cite this article: Norouzi H, Rabbani Khorasgani M, Danesh A. An Increase in Antimicrobial Effects of Standard Antibiotics in Combination with the Active Metabolites Isolated from Marine Streptomyces: A Laboratory Study. J Rafsanjan Univ Med Sci 2020; 18 (10): 1017-34 [Farsi]
[1]- PhD Student, Dept. of Biology, Faculty of Sciences, University of Isfahan, Isfahan, Iran, ORCID: 0000-0003-2652-5502
H. Norouzi[1], M. Rabbani Khorasgani[2], A. Danesh[3]
Received: 10/11/2018 Sent for Revision: 04/02/2019 Received Revised Manuscript: 16/06/2019 Accepted: 01/07/2019
Background and Objectives: Combination therapy has been considered as a potential approach to overcome antimicrobial resistance. In this study the antimicrobial effects of active compounds produced by some marine Streptomyces spp. in combination with some standard antibiotics against multidrug-resistant pathogens was investigated.
Materials and Methods: In this laboratory study, the bacteria isolated from Caspian Sea were tested for their ability to produce antimicrobial compounds active against some drug-resistant pathogens using disc diffusion methods. Then, the producer strains were cultivated in suitable liquid media. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the ethyl acetate extracts were measured against some drug-resistant species including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) using microbroth dilution technique. Data was analysed using paired t-test.
Results: In the first screening, strains MN2, MN39, MN40 and MN41 showed a broad antimicrobial activity against MRSA, VRE, Salmonella typhi and pseudomonas aeruginosa, among which, the best MIC against MRSA was obtained from strain MN39 at 280 (µg/ml). These extracts in combination with some standard antibiotics resulted in a noticeable improved antimicrobial activity against multidrug-resistant pathogens, while in some cases the activity was decreased.
Conclusion: The bioactive compounds produced by actinomyces possess remarkable antimicrobial properties against drug-resistant pathogens when used in a combination therapy with standard antibiotics which requires further research in the future.
Key words: Marine Streptomyces, Multidrug-resistant pathogens, Antimicrobial effects
Funding: This study did not have any funds.
Conflict of interest: None declared.
Ethical approval: The Ethics Committee of Mashhad University of Medical Sciences approved the study (IR.MUMS.REC.1394.556).
How to cite this article: Norouzi H, Rabbani Khorasgani M, Danesh A. An Increase in Antimicrobial Effects of Standard Antibiotics in Combination with the Active Metabolites Isolated from Marine Streptomyces: A Laboratory Study. J Rafsanjan Univ Med Sci 2020; 18 (10): 1017-34 [Farsi]
[2]-Associate Prof., Dept. of Biology, Faculty of Sciences, University of Isfahan, Isfahan, Iran, ORCID: 0000-0002-4043-9216
[3]- Assistant Prof., Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran, ORCID: 000-0002-1122-6641
(Corresponding Author) Tel: )051) 31801202, Fax: (051) 38823251, E-mail: DaneshA@mums.ac.ir
(Corresponding Author) Tel: )051) 31801202, Fax: (051) 38823251, E-mail: DaneshA@mums.ac.ir
Type of Study: Research |
Subject:
Microbiology
Received: 2018/11/10 | Accepted: 2019/07/1 | Published: 2020/01/20
Received: 2018/11/10 | Accepted: 2019/07/1 | Published: 2020/01/20
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
